Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
Clinical trial NCT05959356 · RECRUITING
Trial details
- NCT number
- NCT05959356
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-09
- Primary completion
- 2026-12-31
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.